Healthcare Industry News: laryngoscope
News Release - April 28, 2011
Entellus Medical(TM) Study Demonstrates XprESS(TM) Multi-Sinus Dilation Tool Safe and Effective in Treatment of Chronic Sinusitis
MINNEAPOLIS--(Healthcare Sales & Marketing Network)-- Results presented by Dr. David Brodner today during the annual Combined Otolaryngology Spring Meeting in Chicago demonstrate that Entellus Medical’s XprESS Multi-Sinus Dilation Tool may be used safely and with a high technical success rate in conjunction with traditional functional endoscopic sinus surgery (FESS) tools to treat patients with chronic sinusitis. Further, one-month data show patients experience a statistically significant improvement in quality of life related to their sinusitis symptoms.The presentation, entitled “Initial Results of a Novel, Multi-Functional, Multi-Sinus Balloon Dilation Tool,” reviewed the data from a prospective study of 50 patients who underwent balloon dilation of the frontal recess and/or sphenoid sinus ostia. In 98% of procedures, doctors were able to successfully dilate the targeted sinuses. XprESS demonstrated an excellent safety profile, as no serious adverse events were reported. Follow-up on this population will continue at six and 12 months to affirm durability of symptom improvement and patency of the sinuses treated with balloon dilation.
The Entellus XprESS Multi-Sinus Dilation Tool is used for the treatment of the frontal, sphenoid and maxillary sinuses either alone or as part of a traditional FESS. XprESS combines a balloon catheter with a malleable sinus seeker that can be customized based on patient anatomy, and enables a physician to cost-effectively access and use balloon dilation to treat multiple sinuses with a single device while potentially reducing the amount of tissue loss as compared to traditional FESS procedures.123
According to Dr. Brodner, “XprESS is an easy-to-use technology that provides physicians with a versatile, more ergonomic tool to treat chronic sinusitis patients, and these early results demonstrate that XprESS is safe and provides patients relief from sinusitis-related symptoms.”
About Entellus Medical
Entellus Medical delivers minimally invasive therapeutic solutions for patients who suffer from sinusitis. Based in Maple Grove, Minn., Entellus Medical manufactures, markets, and distributes FinESS™ Sinus Treatment which breaks the cycle of recurring sinusitis with immediate relief and lasting results and XprESS™ Multi-Sinus Dilation Tool that enables ENT physicians to treat multiple sinuses with one tool that is familiar and easy to use. For more information about Entellus Medical and XprESS Multi-Sinus Dilation Tool visit www.entellusmedical.com or call 763/463-1595.
1 James Stakiewicz, et.al., Transantral, Endoscopically Guided Balloon Dilation of the Ostiomeatal Complex for Chronic Rhinosinusitis Under Local Anesthesia, Am. J. Rhinol. Allergy 23, 1-00 (2009).
2 Ahmet Kutluhan, et.al., Endoscopic Balloon Dilation Sinuplasty Including Ethmoidal Air Cells in Chronic Rhinosinusitis, Annals of Oto, Rhin and Lary 118(12):881-886 (2009).
3 Kevin C. Welch, et.al., A Contemporary Review of Endoscopic Sinus Surgery: Techniques, Tools, Outcomes, 119 laryngoscope 2258-68 (Nov. 2009).
Source: Entellus Medical
Issuer of this News Release is solely responsible for its
content.
Please address inquiries directly to the issuing company.
